Corient Private Wealth’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Corient Private Wealth's RGEN Position: Q2 2026 in Review
Corient Private Wealth increased its Repligen (RGEN) stake by 421% in Q2 2026, buying an estimated $1.12M and bringing the position to 11,319 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1546.
Corient Private Wealth first reported a position in RGEN in Q4 2022 and has held it in 15 quarters since. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Corient Private Wealth held 11,319 shares of Repligen worth $1.54M as of Q2 2026.
- Corient Private Wealth bought 9,146 Repligen shares in Q2 2026, an estimated $1.12M.
- Repligen made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1546 holding.
- Corient Private Wealth first reported a position in Repligen in Q4 2022 and has held it in 15 quarters since.
- 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.